The cancer drug Erbitux prolonged the lives of patients with advanced lung cancer by five weeks, according to a new clinical study described as an important gain for such individuals. "Patients with ...
The body has natural defenses to fight cancers but in the case of lung cancer, and of other cancers, the cancerous cells can hide from those natural defenses and keep multiplying. In the trial of ...
In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.
In Thursday's Health Beat, Mandy Gaither has more on how one man went from a two-month life expectancy to living cancer-free.
People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results